Top Markets
#1 Official Trump Official Trump +42.55%
#2 Melania Meme Melania Meme +25.21%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +19.59%
#4 Mubarak Mubarak +19.33%
#5 EXOD EXOD +18.93%
#6 Unit Pump Unit Pump +15.99%
#7 Pump.fun Pump.fun +15.99%
#8 Nockchain Nockchain +15.79%
#9 Wrapped POL Wrapped POL +14.85%
#10 POL (ex-MATIC) POL (ex-MATIC) +13.79%
Coin of the day
Official Trump Official Trump
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
Classificação em ações #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
Preço da ação
$19.30
Última sincronização: 2023-12-26
Valor de mercado
$72.77M
Variação (1 dia)
6.22%
Variação (1 ano)
0.00%
País
US
Negociar Aeglea BioTherapeutics, Inc. (AGLE)

Categoria

Healthcare
Lucros da Aeglea BioTherapeutics, Inc. (AGLE)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Aeglea BioTherapeutics, Inc., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Aeglea BioTherapeutics, Inc. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH